» Articles » PMID: 2610358

Variation in Enzymatic Transient Gene Expression Assays

Overview
Journal Anal Biochem
Publisher Elsevier
Specialty Biochemistry
Date 1989 Nov 1
PMID 2610358
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

We examined causes for high variability in data from enzymatic transient gene expression assays. Our results strongly suggest that variation in transfection efficiency is the major cause of data variation and can seriously compromise valid interpretation of data. We compared averaging data from multiple transfections and cotransfection of a second reporter gene as methods for correcting for variation in transfection efficiency. We found that transfection efficiency can be so highly variable that neither method necessarily overcomes the resulting bias in data. Depending upon the degree in variation in transfection efficiency, a combination of the two methods may be advisable. The need to normalize data for transfection efficiency is dependent upon the difference in strengths of promoters being tested and the relative variability of the transfection method used. We also show that the level of reporter gene expression between transfection experiments performed on different days can vary by more than 10-fold.

Citing Articles

Biological Screening and Crystallographic Studies of Hydroxy γ-Lactone Derivatives to Investigate PPARγ Phosphorylation Inhibition.

Capelli D, Cazzaniga G, Mori M, Laghezza A, Loiodice F, Quaglia M Biomolecules. 2023; 13(4).

PMID: 37189440 PMC: 10136296. DOI: 10.3390/biom13040694.


A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE).

Leuci R, Brunetti L, Laghezza A, Piemontese L, Carrieri A, Pisani L Molecules. 2022; 27(3).

PMID: 35164223 PMC: 8839882. DOI: 10.3390/molecules27030958.


Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes.

Yasmin S, Capone F, Laghezza A, Dal Piaz F, Loiodice F, Vijayan V Sci Rep. 2017; 7(1):14453.

PMID: 29089569 PMC: 5663708. DOI: 10.1038/s41598-017-14776-0.


Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis.

Brusotti G, Montanari R, Capelli D, Cattaneo G, Laghezza A, Tortorella P Sci Rep. 2017; 7(1):5777.

PMID: 28720829 PMC: 5516003. DOI: 10.1038/s41598-017-05666-6.


Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode.

Capelli D, Cerchia C, Montanari R, Loiodice F, Tortorella P, Laghezza A Sci Rep. 2016; 6:34792.

PMID: 27708429 PMC: 5052532. DOI: 10.1038/srep34792.